Physical Training for People With Parkinson's Disease and Multiple Sclerosis: Effect on Mind and Body

Status unknownNot a drug-phase studyProgressive MSNCT05357638

We could not find results for this trial

What it found

No results found

We found no results in the registry or in papers.

What was tested

Treatment tested

  • High Intensity Interval Training (HIIT)
  • Continuous Aerobic Training (CAT)
  • Movement Advice

What it measured

Main measures

  • Change in anxiety and depressive symptoms

    Baseline (week 0), week 4, week 12, week 16

    Mood and sleep

Other measures (24)

  • Change in disease severity

    Baseline (week 0), week 4, week 12, week 16

    Disability progression
  • Change in cognitive function (i.e., ability to inhibit cognitive interference)

    Baseline (week 0), week 4, week 12, week 16

    Thinking and memory
  • Change in cognitive function (i.e., mental flexibility)

    Baseline (week 0), week 4, week 12, week 16

    Thinking and memory
  • Change in cognitive function (i.e., range of cognitive operations: motor speed, attention, and visuoperceptual functions)

    Baseline (week 0), week 4, week 12, week 16

    Thinking and memory
  • Change in fatigue

    Baseline (week 0), week 4, week 12, week 16

    FatiguePhysical function
  • Change in sleep quality

    Baseline (week 0), week 4, week 12, week 16

    Mood and sleep
  • Change in well-being

    Baseline (week 0), week 4, week 12, week 16

  • Change in quality of life

    Baseline (week 0), week 4, week 12, week 16

    Quality of life (reported by participants)
  • Change in motor capacity (i.e., walking speed)

    Baseline (week 0), week 4, week 12, week 16

    Walking and mobility
  • Change in motor capacity (i.e., lower extremity function, mobility, and fall risk)

    Baseline (week 0), week 4, week 12, week 16

    Walking and mobility

Who could take part

Progressive MS · 18 and over

Show the full criteria

Inclusion criteria

* Diagnosis of Parkinson's Disease (PD) or Progressive Multiple Sclerosis (MS) * Hoehn \& Yahr stage \<4 (PD), Expanded Disability Status Scale score \<6 (MS) * Anxiety and/or depressive symptoms; Hospital Anxiety and Depression Scale (HADS) score >=8 points on HADS-A and/or HADS-D * Sufficient cognitive ability to understand training instructions; Montreal Cognitive Assessment score >21 points * Able to participate in intensive physical training, no contra-indications for exercise * Stable medication regime for at least 4 weeks prior to inclusion * Age >=18 years

Exclusion criteria

* Participation in intensive exercise program in the month prior to inclusion * Relapse in the month prior to inclusion (MS) * Symptoms indicating cardiovascular, pulmonary, or metabolic disease or cardiovascular, pulmonary, or metabolic disease which are not under control with medication * abnormal electrocardiography in rest

As registered. Criteria can change, so ask the trial team or your neurologist.

About this trial

In the sponsor's words

People with Parkinson's disease and Multiple Sclerosis experience disabling motor and non-motor symptoms, which respond insufficiently to medication. To adequately alleviate disease burden, physical training is increasing acknowledged as an assisting therapy; however, the optimal dose of exercise in unknown.

Papers

    Loading reviews and guidelines…

    History

      1. Started

        May 2022

      2. Main results due

        May 2025

      3. Finished

        Nov 2025

      Assembled by software from public sources.